Clinical trial Recruiting at 1 site Interventional Ages 20 to 70

Comparing bone gain using 3D printed zirconia barriers and titanium mesh

Official title: Clinical and Radiographic Evaluation of Bone Gain Using Customized 3D Printed Zirconia Barrier Versus Titanium Mesh in Combined Ridge Defects in The Aesthetic Zone: A Randomized Clinical Trial

Run by Cairo University · NCT06559605 · Data updated 2026-11-12

This study is testing whether 3D printed zirconia barriers can help people with bone defects in their mouths gain more bone than traditional titanium mesh.

More Alveolar Bone Loss trials

Quick facts

Study typeInterventional
Ages20 Years to 70 Years
SexAll
Enrollment26 (estimated)
SponsorCairo University
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Cairo)
StatusRecruiting
StartedMay 22, 2024
Main results expectedMay 22, 2026
Study endsNovember 22, 2026
Registry record updatedAugust 20, 2024
Trial IDNCT06559605 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 20-70 with specific bone loss characteristics and good oral hygiene.

Probably not a fit

Patients with pathological lesions, uncontrolled systemic diseases, or poor oral hygiene may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness of customized 3D printed zirconia barriers compared to traditional titanium mesh in promoting bone gain in patients with combined ridge defects in the esthetic zone. The study involves a randomized design with 26 sites, where patients will be assigned to receive either the zirconia barrier or titanium mesh after thorough pre-operative assessments. The primary outcome is the amount of bone gained, measured both clinically and radiographically, following the procedure. The trial aims to address the complications associated with titanium mesh while exploring the potential benefits of zirconia in bone augmentation.

Why it matters

Potential benefit: If successful, this study could provide a more effective and less complication-prone method for bone augmentation in dental procedures.

How similar studies have gone: While the use of titanium mesh is well-established, the application of customized 3D printed zirconia barriers is a novel approach that has not been extensively tested in similar studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age: 20-70 years.
* Bone width less than 4mm
* Vertical bone height less than 9mm
* Periodontally sound neighboring teeth
* Patients with sound vertical occlusal bite dimension
* Good oral hygiene (full mouth plaque control record \[PCR\] \< 25%,full mouth bleeding on probing (BOP) \< 25% .
* Patients demonstrating understanding and commitment to the post-operative care regime and the study follow up timeline.
* Good general health (including participants with well-controlled systemic disease)

Exclusion Criteria:

1. Pathological lesions (abscess-cyst-acute infection) in the defect site
2. Systemic diseases that would interfere with bone metabolism
3. Uncontrolled diabetic patients
4. Ongoing treatment or a history of recent chemotherapy or radiotherapy
5. Poor oral hygiene after hygienic phase (Plaque control record over 30%) or Active periodontal disease

Where it's running

  • Cairo university
    Cairo, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.